Practitioner Profile

Kevin Tay

Oncologist - Cancer

Clinical Focus

Dr. Tay’s subspecialty interest is in women related cancers such as breast cancers and gynaecological cancers, soft tissue and bone sarcomas and also hematological malignancies such as lymphoma, multiple myeloma, and leukemia.

Professional Statement

Dr. Kevin Tay is a Consultant Medical Oncologist with the Oncocare Cancer Center and also a Visiting Consultant at the National Cancer Center Singapore. Dr. Tay received his medical degree from the National University of Singapore, School of Medicine and did his post-graduate training in Internal Medicine at the University of Hawaii and his Medical Oncology fellowship at the National Cancer Institute (NCI), National Institute of Health (NIH) in USA. Dr. Tay was also appointed Chief Resident and Chief Fellow during both his residency and fellowship program respectively.  He currently holds American Board certifications for the practice of Internal Medicine and Medical Oncology.

Dr. Tay is actively collaborating with other leading Asian researchers from Korea, Taiwan, and Hong Kong as well with his former colleagues at the National Institute of Health in USA in genomic oncology research. Dr. Tay has also published widely in numerous journals, including the Nature Genetics, the Journal of Clinical Oncology, The Lancet Hematology, American Journal of Medicine, Leukemia & Lymphoma and Seminars in Hematology. He is also a member of the SingHealth Institutional Review Board, designated to approve, monitor and review the research activities within SingHealth since 2010.

Qualifications
  • MBBS (Singapore)
  • ABIM Int. Med (USA)
  • ABIM Med Onc (USA)
Fellowship/Membership
  • FAMS (Medical Oncology)
  • Member, American Society of Clinical Oncology
Spoken Languages

English

OncoCare Cancer Centre @ Novena

38 Irrawaddy Road, (Mount Elizabeth Novena Hospital), #09-59/60/61/62/63, Mt Elizabeth Novena Specialist Ctr, Singapore 329563

Opening Hours

Weekdays
8.30 AM-5.30 PM
Saturday
8.30 AM-1 PM

Accepted Insurance

AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential

Accepted Panel

GetDoc

Our Website

https://www.oncocare.sg/

Our Story

Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.

We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.

Our core values are excellence, compassion and integrity.

OncoCare Cancer Centre @ Mount Alvernia

820 Thomson Road, #08-53, Medical Centre D, Mount Alvernia Hospital, Singapore 574623

Opening Hours

Weekdays
8.30 AM-5.30 PM
Saturday
8.30 AM-1 PM

Accepted Insurance

AIAAXAAllianzFullertonGreat EasternMHCNTUC IncomeParkway ShentonPrudential

Accepted Panel

GetDoc

Our Website

https://www.oncocare.sg/

Our Story

Since its founding in 2007, OncoCare Cancer Centre in Singapore has been committed to providing the best available cancer care to our patients through expert, personalized treatments, driven by state of the art knowledge and making a difference through efficient delivery, effective communication, and compassionate touch. We seek to cure, to relieve and to partner our patients on their cancer journey by using our understanding of the detection, diagnosis, treatment, and prevention of cancer. We aim to reduce toxicity, control symptoms, prevent disfigurement, eliminate pain, and emotional distress associated with cancer-directed therapy.

We believe that today’s research leads to tomorrow’s cure and our doctors are actively involved in clinical research and trials, have a dynamic collaboration with regional cancer institutions and laboratories. We have access to the latest commercial imaging, molecular genetic laboratories associated with world-class science and technology.

Our core values are excellence, compassion and integrity.